Bleeding patterns of women using extended regimens of the contraceptive vaginal ring

Contraception

Volumn 75, Issue 3, 2007, Pages 204-208

  Barreiros, Fernando Augusto ^a   Guazzelli, Cristina Aparecida Falbo ^a   de Araújo, Fábio Fernando ^a   Barbosa, Ricardo ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Contraceptive vaginal ring; Cycle control; Extended regimens; Hormonal contraceptive

Indexed keywords

ETHINYLESTRADIOL; ETONOGESTREL;

ADULT; AMENORRHEA; ARTICLE; CONTROLLED STUDY; DRUG WITHDRAWAL; FEMALE; HUMAN; HUMAN EXPERIMENT; MENSTRUAL CYCLE; MENSTRUATION; MENSTRUATION DISORDER; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PATIENT SATISFACTION; PROSPECTIVE STUDY; TREATMENT DURATION; UTERINE BLEEDING PATTERN; VAGINA RING;

ADOLESCENT; ADULT; CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVE DEVICES, FEMALE; DESOGESTREL; DRUG COMBINATIONS; ESTROGENS; ETHINYL ESTRADIOL; FEMALE; HUMANS; MENSTRUATION; MENSTRUATION DISTURBANCES; PROSPECTIVE STUDIES;

EID: 33846786649     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2006.10.009     Document Type: Article

References (13)

1. Sulak P.J., Kuehl T.J., Ortiz M., and Shull B.L. Acceptance of altering the standard 21-day/7-day oral contraceptive regimen to delay menses and reduce hormone withdrawal symptoms. Am J Obstet Gynecol 186 (2002) 1142-1149
2. Trussell J, Vaughan B. Contraceptive failure, method-related discontinuation and resumption of use: results from the 1995 National Survey of Family Growth. Fam Plann Perspect 1999:64-72, 93.
3. Aubeny E., Buhler M., Colau J.C., Vicaut E., Zadikian M., and Childs M. Oral contraception: patterns of non-compliance. The Coraliance study. Eur J Contracept Reprod Health Care 7 (2002) 155-161
4. Roumen F., Apter D., Mulders T., and Dieben T. Efficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyl oestradiol. Hum Reprod 16 (2001) 469-475
5. Bjarnadóttir R.I., Tuppurainen M., and Killick S.R. Comparison of cycle control with a combined contraceptive vaginal ring and oral levonorgestrel/ethinylestradiol. Am J Obstet Gynecol 186 (2002) 389-395
6. Miller L., Verhoeven C., and Hout J. Extended regimens of the contraceptive vaginal ring. Obstet Gynecol 106 (2005) 473-482
7. World Health Organization. Combined injectable contraceptives, patch and ring. In: World Health Organization (Ed). Medical eligibility criteria for contraceptive use. Reproductive health and research. 3rd ed. (2004), World Health Organization, Geneva 3-17
8. World Health Organization. Special programme of research, development and research training in human reproduction. The analysis of vaginal bleeding patterns induced by fertility regulating methods. Contraception 34 (1986) 253-260
9. Rodriguez G., Faundes-Latham A., and Atkinson L.A.N. Approach to analysis of menstrual patterns in the clinical evaluation of contraceptives. Stud Fam Plann 7 (1976) 42-51
10. Altman D. Practical statistics for medical research (1991), Chapman and Hall, London 250
11. FDA approves Nuvaring contraceptive implant. J Gend Specif Med 5 (2002) 6
12. Timmer C.J., and Mulders T.M. Pharmacokinetics of etonogestrel and ethinylestradiol released from a combined contraceptive vaginal ring. Clin Pharmacokinet 39 (2000) 233-242
13. Rosenberg M.J., Meyers A., and Roy V. Efficacy, cycle control, and side effects of low- and lower-dose oral contraceptives: a randomized trial of 20 micrograms and 35 μg estrogen preparations. Contraception 60 (1999) 321-329